Opioids in chronic pain
R Przewłocki, B Przewłocka - European journal of pharmacology, 2001 - Elsevier
The advance in our understanding of the biogenesis of various endogenous opioid
peptides, their anatomical distribution, and the characteristics of the multiple receptors with …
peptides, their anatomical distribution, and the characteristics of the multiple receptors with …
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
A Barber, R Gottschlich - Expert opinion on investigational drugs, 1997 - Taylor & Francis
Despite the recent introduction of a number of new compounds, there has of late been a
cooling of interest by pharmaceutical companies in the development of centrally-active …
cooling of interest by pharmaceutical companies in the development of centrally-active …
[图书][B] Opioide in der Medizin
E Freye - 2009 - books.google.com
Erfahren Sie alles über Opioide, was Sie schon immer wissen wollten:-Physiologie des
Schmerzgeschehens,-Wirkungsweise, Nebenwirkungen von Opioiden,-Indikationen und …
Schmerzgeschehens,-Wirkungsweise, Nebenwirkungen von Opioiden,-Indikationen und …
Immunohistochemical localization of μ-opioid receptors in human dental pulp
L Jaber, WD Swaim, RA Dionne - Journal of endodontics, 2003 - Elsevier
Studies in both animal and clinical models suggest that opioids exert their analgesic effects
not only through activation of receptors in the CNS but also through interaction with …
not only through activation of receptors in the CNS but also through interaction with …
Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review
AW Mangel, GA Hicks - Clinical and Experimental …, 2012 - Taylor & Francis
Irritable bowel syndrome (IBS) is a multifactorial condition with principal symptoms of pain
and altered bowel function. The kappa-opioid agonist asimadoline is being evaluated in …
and altered bowel function. The kappa-opioid agonist asimadoline is being evaluated in …
Stress, opioid peptides, and their receptors
R Przewŀocki - Hormones, brain and behavior, 2002 - Elsevier
Publisher Summary This chapter discusses the possible involvement of opioids in mediating
physiological as well as psychological reactions to stress. It focuses on the neurobiological …
physiological as well as psychological reactions to stress. It focuses on the neurobiological …
[图书][B] Opioide in der Medizin: Wirkung und Einsatzgebiete zentraler Analgetika
E Freye - 2013 - books.google.com
Sind Opioide noch immer die wirkungsstärksten Analgetika im Armentarium eines
Therapeuten, so stellen jedoch Unsicherheiten in der Wahl des Produktes, der Dosierung …
Therapeuten, so stellen jedoch Unsicherheiten in der Wahl des Produktes, der Dosierung …
Constitutive and inducible nitric oxide synthases after dynorphin-induced spinal cord injury
It has recently been demonstrated that selective inhibition of both neuronal constitutive and
inducible nitric oxide synthases (ncNOS and iNOS) is neuroprotective in a model of …
inducible nitric oxide synthases (ncNOS and iNOS) is neuroprotective in a model of …
[HTML][HTML] Exploring the Painless Nature and Potential Mechanisms of Asymptomatic Irreversible Pulpitis: A Narrative Review
DP Cabrera-Abad, VC Jara-Vergara… - The Open Dentistry …, 2024 - opendentistryjournal.com
Background Considering the extensive innervation of the pulp tissue, asymptomatic
irreversible pulpitis (AIP) or “silent pulpitis” represents a confounding clinical condition …
irreversible pulpitis (AIP) or “silent pulpitis” represents a confounding clinical condition …
Pharmakokinetik der Opioide: Bedeutung für den praktischen Einsatz
E Freye, E Freye - Opioide in der Medizin, 2004 - Springer
Um an den spezifischen Opioidrezeptor im ZNS zu gelangen, muss das Opioid nach einer
intravenösen, intramuskulären oder subkutanen Injektion die Blut-Hirn-Schranke …
intravenösen, intramuskulären oder subkutanen Injektion die Blut-Hirn-Schranke …